Skip to main content
Premium Trial:

Request an Annual Quote

European Commission Approves GE Acquisition of Amersham

NEW YORK, Jan. 21 (GenomeWeb News) - European Union regulators today gave a thumbs-up to General Electric's proposed $9.5 billion acquisition of Amersham.


In a statement, the Commission said that its investigation showed that its concerns about possible "conglomerate effects" from a merger were unlikely.


". . . Neither GE nor Amersham hold dominant positions in their respective products in Europe," the Commission wrote. "The proposed acquisition does not lead to horizontal overlaps."


Further, the Commission said that both companies face competition from manufacturers Philips, Siemens, and Toshiba, as well as the pharmaceutical companies such as Schering, Bristol-Myers Squibb, Tyco/Mallinckrodt, and Bracco.


Conglomerate effects include, the Commission said, technical tying of Amersham's products to work best with GE equipment, or the possibility of bundling products at a better price than the sum of the individual products.


The Commission "ascertained" that there was "perfect interoperability between the different existing equipment and pharmaceutical products, and that such interoperability was unlikely to be reduced when new products come to the market."


The Commission said that antitrust authorities in the US and Canada cooperated with its investigation.


Click here to see European Commission statement.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.